• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚年遗传性疾病的症状前检测。药物流行病学考量。

Presymptomatic testing for genetic diseases of later life. Pharmacoepidemiological considerations.

作者信息

Rossiter B J, Caskey C T

机构信息

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.

出版信息

Drugs Aging. 1995 Aug;7(2):117-30. doi: 10.2165/00002512-199507020-00006.

DOI:10.2165/00002512-199507020-00006
PMID:7579783
Abstract

As the Human Genome Project gathers speed, new disease genes are rapidly being found. Important as these discoveries are, they are only the beginning of the process of characterising, diagnosing and treating genetic diseases. We now have the potential to predict the onset of many disorders before the appearance of clinical symptoms, even though treatment is not always available. In this review we have used a number of examples to illustrate various aspects of the presymptomatic diagnosis of genetic disease and, where possible, late-onset disorders have been chosen as examples. When treatment is available, the diagnosis of a disease before appearance of symptoms can greatly improve the prognosis. When treatment is not available, reasons to undergo presymptomatic testing may not be so obvious. However, appropriate lifestyle changes or medical surveillance can sometimes delay onset or decrease severity of a disorder. Even if no treatment is available, genetic testing and counselling for the patient and family members can provide useful information for future planning.

摘要

随着人类基因组计划加速推进,新的疾病基因正被迅速发现。尽管这些发现意义重大,但它们仅仅是对遗传性疾病进行特征描述、诊断和治疗过程的开端。我们现在有能力在临床症状出现之前预测许多疾病的发病情况,即便并非总能进行治疗。在本综述中,我们使用了若干实例来说明遗传性疾病症状前诊断的各个方面,并且在可能的情况下,选择了迟发性疾病作为实例。当有治疗方法时,在症状出现之前对疾病进行诊断能够极大地改善预后。当没有治疗方法时,进行症状前检测的理由可能就不那么明显了。然而,适当的生活方式改变或医学监测有时可以延迟疾病的发作或减轻其严重程度。即使没有治疗方法,对患者及其家庭成员进行基因检测和咨询也可为未来规划提供有用信息。

相似文献

1
Presymptomatic testing for genetic diseases of later life. Pharmacoepidemiological considerations.晚年遗传性疾病的症状前检测。药物流行病学考量。
Drugs Aging. 1995 Aug;7(2):117-30. doi: 10.2165/00002512-199507020-00006.
2
Quality assessment of genetic counseling process in the context of presymptomatic testing for late-onset disorders: a thematic analysis of three review articles.迟发性疾病症状前检测背景下遗传咨询过程的质量评估:三篇综述文章的主题分析
Genet Test Mol Biomarkers. 2012 Jan;16(1):36-45. doi: 10.1089/gtmb.2011.0023. Epub 2011 Aug 5.
3
When genetic screening is useful, but not used.当基因筛查有用时却未被采用。
LDI Issue Brief. 2011 Jul-Aug;16(8):1-4.
4
The clinical geneticist and the "new genetics".
Med J Aust. 2003 May 5;178(9):458-62. doi: 10.5694/j.1326-5377.2003.tb05291.x.
5
What counts as effective genetic counselling for presymptomatic testing in late-onset disorders? A study of the consultand's perspective.对于迟发性疾病的症状前检测,什么才算是有效的遗传咨询?一项从咨询者角度开展的研究。
J Genet Couns. 2013 Aug;22(4):437-47. doi: 10.1007/s10897-012-9561-3. Epub 2013 Jan 7.
6
A theoretical psychological perspective on predictive testing for late onset hereditary diseases.关于迟发性遗传性疾病预测性检测的理论心理学视角。
Genet Couns. 2007;18(4):367-78.
7
[Presymptomatic testing and predictive testing].[症状前检测和预测性检测]
Nihon Rinsho. 2005 Dec;63 Suppl 12:93-8.
8
Candidate disorders for gene therapy: newborn screening facilitates ascertainment of presymptomatic individuals.
Hum Gene Ther. 2008 Mar;19(3):213-6. doi: 10.1089/hum.2007.1211.
9
Impact of genome research on children and their families.基因组研究对儿童及其家庭的影响。
J Pediatr Nurs. 2000 Aug;15(4):207-11. doi: 10.1053/jpdn.2000.8043.
10
The human genome project is complete. How do we develop a handle for the pump?
Am J Epidemiol. 2003 Apr 15;157(8):667-73. doi: 10.1093/aje/kwg048.

引用本文的文献

1
ALKBH7 Variant Related to Prostate Cancer Exhibits Altered Substrate Binding.与前列腺癌相关的ALKBH7变体表现出改变的底物结合。
PLoS Comput Biol. 2017 Feb 23;13(2):e1005345. doi: 10.1371/journal.pcbi.1005345. eCollection 2017 Feb.
2
Hypothesis driven single nucleotide polymorphism search (HyDn-SNP-S).假说驱动的单核苷酸多态性搜索(HyDn-SNP-S)。
DNA Repair (Amst). 2013 Sep;12(9):733-40. doi: 10.1016/j.dnarep.2013.06.001. Epub 2013 Jul 5.

本文引用的文献

1
Sickle cell anemia a molecular disease.镰状细胞贫血是一种分子疾病。
Science. 1949 Nov 25;110(2865):543-8. doi: 10.1126/science.110.2865.543.
2
A SIMPLE PHENYLALANINE METHOD FOR DETECTING PHENYLKETONURIA IN LARGE POPULATIONS OF NEWBORN INFANTS.一种用于在大量新生儿群体中检测苯丙酮尿症的简易苯丙氨酸方法。
Pediatrics. 1963 Sep;32:338-43.
3
Molecular characterization of cytogenetic alterations associated with the Beckwith-Wiedemann syndrome (BWS) phenotype refines the localization and suggests the gene for BWS is imprinted.与贝克威思-维德曼综合征(BWS)表型相关的细胞遗传学改变的分子特征分析优化了定位,并提示BWS基因是印记基因。
Hum Mol Genet. 1993 May;2(5):549-56. doi: 10.1093/hmg/2.5.549.
4
The multistep nature of cancer.癌症的多步骤特性。
Trends Genet. 1993 Apr;9(4):138-41. doi: 10.1016/0168-9525(93)90209-z.
5
Identification of the von Hippel-Lindau disease tumor suppressor gene.冯·希佩尔-林道病肿瘤抑制基因的鉴定。
Science. 1993 May 28;260(5112):1317-20. doi: 10.1126/science.8493574.
6
Inherited breast and ovarian cancer. What are the risks? What are the choices?遗传性乳腺癌和卵巢癌。风险有哪些?有哪些选择?
JAMA. 1993 Apr 21;269(15):1975-80.
7
Relationship between parental trinucleotide GCT repeat length and severity of myotonic dystrophy in offspring.父母三核苷酸GCT重复序列长度与子代强直性肌营养不良严重程度之间的关系。
JAMA. 1993 Apr 21;269(15):1960-5.
8
Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.家族性乳腺癌和卵巢癌的基因连锁分析:来自214个家庭的结果。乳腺癌连锁协会。
Am J Hum Genet. 1993 Apr;52(4):678-701.
9
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.一个含有三核苷酸重复序列的新基因,该序列在亨廷顿病染色体上呈扩增且不稳定状态。亨廷顿病协作研究组。
Cell. 1993 Mar 26;72(6):971-83. doi: 10.1016/0092-8674(93)90585-e.
10
A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor.一种新的类肌动蛋白结合蛋白、埃兹蛋白、根蛋白样基因是2型神经纤维瘤病肿瘤抑制基因的候选基因。
Cell. 1993 Mar 12;72(5):791-800. doi: 10.1016/0092-8674(93)90406-g.